S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Better Than Oil Stocks? (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
NYSEMKT:PHGE

BiomX (PHGE) Stock Forecast, Price & News

$0.33
-0.01 (-2.94%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.33
$0.36
50-Day Range
$0.32
$0.43
52-Week Range
N/A
Volume
12,810 shs
Average Volume
28,619 shs
Market Capitalization
$15.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50

BiomX MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,263.6% Upside
$4.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.44) to ($0.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars


PHGE stock logo

About BiomX (NYSEMKT:PHGE) Stock

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

PHGE Price History

PHGE Stock News Headlines

BiomX GAAP EPS of -$0.12 beats by $0.02
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
PHGE - BiomX Inc.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
BiomX Inc. (PHGE-WT)
BiomX Stock (AMEX:PHGE), Dividends
BiomX Announces $7.5 Million Private Placement
BiomX: Top 10 Undervalued Healthcare Stocks on ASE (PHGE)
PHGE_u Technical Analysis
See More Headlines
Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

PHGE Company Calendar

Last Earnings
5/15/2023
Today
9/29/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEMKT:PHGE
Fax
N/A
Employees
54
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.50
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+1,263.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-28,320,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.70 per share

Miscellaneous

Free Float
44,044,000
Market Cap
$15.17 million
Optionable
Not Optionable
Beta
1.31
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Jonathan Eitan Solomon MBA (Age 46)
    CEO & Director
    Comp: $528.57k
  • Ms. Marina Wolfson CPA (Age 39)
    CFO & Sec.
    Comp: $279.42k
  • Dr. Merav Bassan Ph.D. (Age 57)
    Chief Devel. Officer
    Comp: $356.59k
  • Prof. Rotem Sorek Ph.D.
    Scientific Founder
  • Dr. Eran Elinav M.D.
    Ph.D., Scientific Founder
  • Dr. Timothy K. Lu M.D. (Age 42)
    Ph.D., Scientific Founder
  • Ms. Inbal Benjamini-Elran
    C.H.R.O
  • Mr. Assaf Oron (Age 49)
    Chief Bus. Officer
  • Dr. Inbar Gahali-Sass
    VP of Platform R&D













PHGE Stock - Frequently Asked Questions

Should I buy or sell BiomX stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BiomX in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PHGE shares.
View PHGE analyst ratings
or view top-rated stocks.

What is BiomX's stock price forecast for 2023?

3 brokers have issued 12-month price objectives for BiomX's shares. Their PHGE share price forecasts range from $2.00 to $7.00. On average, they predict the company's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 1,263.6% from the stock's current price.
View analysts price targets for PHGE
or view top-rated stocks among Wall Street analysts.

How have PHGE shares performed in 2023?

BiomX's stock was trading at $0.1870 at the beginning of 2023. Since then, PHGE stock has increased by 76.5% and is now trading at $0.33.
View the best growth stocks for 2023 here
.

When is BiomX's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our PHGE earnings forecast
.

How were BiomX's earnings last quarter?

BiomX Inc. (NYSEMKT:PHGE) issued its quarterly earnings results on Monday, May, 15th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.02.

What other stocks do shareholders of BiomX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BiomX investors own include Abiomed (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), ARCA biopharma (ABIO), AbbVie (ABBV) and AudioEye (AEYE).

What is BiomX's stock symbol?

BiomX trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "PHGE."

How do I buy shares of BiomX?

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BiomX's stock price today?

One share of PHGE stock can currently be purchased for approximately $0.33.

How much money does BiomX make?

BiomX (NYSEMKT:PHGE) has a market capitalization of $15.17 million. The company earns $-28,320,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

How can I contact BiomX?

BiomX's mailing address is 7 PINHAS SAPIR ST. FLOOR 2, NESS ZIONA L3, 7414002. The official website for the company is www.biomx.com. The company can be reached via phone at 972 7 23942377 or via email at noelk@biomx.com.

This page (NYSEMKT:PHGE) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -